Total submissions: 4
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Invitae | RCV001053603 | SCV001217874 | pathogenic | not provided | 2023-10-04 | criteria provided, single submitter | clinical testing | This sequence change creates a premature translational stop signal (p.Arg964*) in the IMPG2 gene. It is expected to result in an absent or disrupted protein product. Loss-of-function variants in IMPG2 are known to be pathogenic (PMID: 20673862). This variant is present in population databases (rs267606875, gnomAD 0.003%). This premature translational stop signal has been observed in individual(s) with retinitis pigmentosa or macular dystrophy (PMID: 20673862, 24876279, 30718709). ClinVar contains an entry for this variant (Variation ID: 3549). For these reasons, this variant has been classified as Pathogenic. |
Dept Of Ophthalmology, |
RCV003887852 | SCV004705601 | pathogenic | Retinal dystrophy | 2023-10-01 | criteria provided, single submitter | research | |
OMIM | RCV000003727 | SCV000023890 | pathogenic | Retinitis pigmentosa 56 | 2010-08-13 | no assertion criteria provided | literature only | |
Department of Clinical Genetics, |
RCV000787843 | SCV000926857 | likely pathogenic | Macular dystrophy | 2018-04-01 | no assertion criteria provided | research |